Chemours Q1 Net Sales $1.4B, Net Loss $29M; Adjusted EBITDA $169M
Chemours Company reported first quarter 2026 financial results, with net sales slightly increasing by 1% year-over-year to $1.4 billion. The company posted a net loss of $29 million, or $0.19 per diluted share, a significant increase from the prior-year quarter's $5 million net loss, primarily due to higher financing costs and selling, general, and administrative expenses. Adjusted EBITDA, however, saw a 2% increase to $169 million. The Thermal & Specialized Solutions segment delivered record first-quarter results, while Titanium Technologies and Advanced Performance Materials segments experienced declines. Additionally, Chemours received approximately $287 million from the sale of its Kuan Yin site, which enabled a €140 million debt repayment, and provided positive guidance for the second quarter and full year 2026.
Key Highlights
- Net Sales were $1.4 billion, up 1% year-over-year.
- Net Loss attributable to Chemours was $29 million, or $0.19 per diluted share.
- Adjusted EBITDA was $169 million, an increase of 2% year-over-year.
- Thermal & Specialized Solutions (TSS) Net Sales were $568 million, up 22% YoY, achieving record Q1 results.
- Titanium Technologies (TT) Net Sales decreased 6% YoY to $559 million.
- Advanced Performance Materials (APM) Net Sales decreased 17% YoY to $243 million due to production constraints.
- Received ~$287 million initial net proceeds from Kuan Yin site sale, used to pay down €140 million debt.
- Q2 2026 Net Sales expected to increase 15-20% sequentially; Adjusted EBITDA $220M-$250M.
- Full-year 2026 Net Sales expected to grow 3-5%; Adjusted EBITDA $800M-$900M.